Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Zenalb 4.5% solution for injection 250ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Albumin human 4.5% solution for injection 500ml bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zenalb 4.5% solution for injection 500ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Albumin human 20% solution for injection 100ml bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zenalb 20% solution for injection 100ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Albumin human 20% solution for injection 50ml bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zenalb 20% solution for injection 50ml bottles (BPL (Bio Products laboratory)) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dolasetron 100mg/5ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dolasetron 100mg/5ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Anzemet I.V. 100mg/5ml solution for injection ampoules (Amdipharm) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 10ml pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 10ml pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 10ml pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 5ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 5ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 5ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 10ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 10ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 50% solution for injection 10ml ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amikacin 500mg/2ml solution for injection vials 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amikin 500mg/2ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amikacin 100mg/2ml solution for injection vials 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amikin 100mg/2ml solution for injection vials (Vianex S.A.) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Heparin sodium 25,000units/5ml solution for injection vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Multiparin 25,000units/5ml solution for injection vials (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium pamidronate 90mg/10ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium pamidronate 90mg/10ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Heparin sodium 25,000units/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Monoparin 25,000units/1ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ropivacaine 75mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Naropin 75mg/10ml solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ropivacaine 20mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium tetradecyl sulfate 0.2% solution for injection 5ml vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 0.2% solution for injection 5ml vials (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium tetradecyl sulfate 0.5% solution for injection 2ml ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 0.5% solution for injection 2ml ampoules (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ropivacaine 100mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium tetradecyl sulfate 3% solution for injection 5ml vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 3% solution for injection 5ml vials (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium tetradecyl sulfate 1% solution for injection 2ml ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 1% solution for injection 2ml ampoules (STD Pharmaceutical Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Naropin 100mg/10ml solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tobramycin 40mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tobramycin 40mg/1ml solution for injection ampoules (Alpharma Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tobramycin 240mg/6ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tobramycin 240mg/6ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tobramycin 20mg/2ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nebcin 20mg/2ml solution for injection vials (King Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 15mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 15mg/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 15mg/2ml solution for injection ampoules (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 15mg/2ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Interferon alfa-2b (rbe) 60million units/1.2ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
IntronA 60million units/1.2ml solution for injection multidose pens (Organon Pharma (UK) Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 500micrograms/10ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 500micrograms/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 500micrograms/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sublimaze 500micrograms/10ml solution for injection ampoules (Janssen-Cilag Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 500micrograms/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules (Aurum Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Heparin sodium 10,000units/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Monoparin 10,000units/10ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Heparin sodium 125,000units/5ml solution for injection vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Multiparin 125,000units/5ml solution for injection vials (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Heparin sodium 25,000units/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Monoparin 25,000units/5ml solution for injection ampoules (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ergometrine 500micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ergometrine 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carnitine 1g/5ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carnitor 1g/5ml solution for injection ampoules (Shire Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hydroxyprogesterone 250mg/1ml solution for injection ampoules 3 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Proluton Depot 250mg/1ml solution for injection ampoules (Schering Health Care Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Clomipramine 25mg/2ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Anafranil 25mg/2ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Iron dextran 100mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
CosmoFer 100mg/2ml solution for injection ampoules (Pharmacosmos UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Neostigmine 2.5mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Neostigmine 2.5mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Neostigmine 2.5mg/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 10% solution for injection 10ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 10% solution for injection 10ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 10% solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 10% solution for injection 10ml ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Robinul-Neostigmine solution for injection 1ml ampoules (Goldshield Healthcare Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/10ml solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/10ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/10ml solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/10ml solution for injection pre-filled syringes (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|